Prostate Cancer - Results from #80

Urethral and bladder dose-effect relations for late genitourinary toxicity following external beam radiotherapy for prostate cancer in the FLAME trial. January 3, 2022

Exploring predictors of and barriers to online prostate cancer community use: A cross-sectional survey of users and non-users. January 3, 2022

The Effect of Corticosteroids on Prostate Cancer Outcome Following Treatment with Enzalutamide: A Multivariate Analysis of the Phase III AFFIRM Trial. January 3, 2022

Five- and seven-year outcomes for image-guided moderately accelerated hypofractionated proton therapy for prostate cancer. January 3, 2022

Immune landscape of human prostate cancer: immune evasion mechanisms and biomarkers for personalized immunotherapy. January 3, 2022

MRI-detectability and histological factors of prostate cancer including intraductal carcinoma and cribriform pattern. December 31, 2021

Implementing the da Vinci SP® without increasing positive surgical margins: experience and pathological outcomes of a prostate cancer referral center. December 31, 2021

Neuroendocrine Carcinoma as an Independent Prognostic Factor for Patients With Prostate Cancer: A Population-Based Study. December 31, 2021

Determination of optimal 68 Ga-PSMA PET/CT imaging time in prostate cancers by total-body dynamic PET/CT. December 31, 2021

Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis. December 31, 2021

Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer. December 30, 2021

Clinically significant prostate cancer (csPCa) detection with various prostate sampling schemes based on different csPCa definitions. December 30, 2021

hsa_circ_0001275 Is One of a Number of circRNAs Dysregulated in Enzalutamide Resistant Prostate Cancer and Confers Enzalutamide Resistance In Vitro. December 30, 2021

Prediction of Clinically Significant Cancer Using Radiomics Features of Pre-Biopsy of Multiparametric MRI in Men Suspected of Prostate Cancer. December 30, 2021

Uptake of 18F-rhPSMA-7.3 in Positron Emission Tomography Imaging of Prostate Cancer: A Phase 1 Proof-of-Concept Study. December 30, 2021

Impact of abiraterone acetate plus prednisone in patients with castration-sensitive prostate cancer and visceral metastases over four years of follow-up: A post-hoc exploratory analysis of the LATITUDE study. December 29, 2021

Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol. December 29, 2021

Population-based randomized trial of screening for clinically significant prostate cancer ProScreen: pilot study. December 29, 2021

Influence of Biopsy Gleason Score on the Risk of Lymph Node Invasion in Patients With Intermediate-Risk Prostate Cancer Undergoing Radical Prostatectomy. December 29, 2021

Comparison of 3 T mpMRI and pelvic CT examinations for detection of lymph node metastases in patients with prostate cancer. December 28, 2021

Page 5 of 1199

email news signup